These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 25783012)
1. Idiopathic Juvenile Osteoporosis: Clinical Experience from a Single Centre and Screening of LRP5 and LRP6 Genes. Franceschi R; Vincenzi M; Camilot M; Antoniazzi F; Freemont AJ; Adams JE; Laine C; Makitie O; Mughal MZ Calcif Tissue Int; 2015 Jun; 96(6):575-9. PubMed ID: 25783012 [TBL] [Abstract][Full Text] [Related]
2. New explanation for autosomal dominant high bone mass: Mutation of low-density lipoprotein receptor-related protein 6. Whyte MP; McAlister WH; Zhang F; Bijanki VN; Nenninger A; Gottesman GS; Lin EL; Huskey M; Duan S; Dahir K; Mumm S Bone; 2019 Oct; 127():228-243. PubMed ID: 31085352 [TBL] [Abstract][Full Text] [Related]
3. Clinical Phenotype and Relevance of LRP5 and LRP6 Variants in Patients With Early-Onset Osteoporosis (EOOP). Stürznickel J; Rolvien T; Delsmann A; Butscheidt S; Barvencik F; Mundlos S; Schinke T; Kornak U; Amling M; Oheim R J Bone Miner Res; 2021 Feb; 36(2):271-282. PubMed ID: 33118644 [TBL] [Abstract][Full Text] [Related]
4. Whole-exome sequencing reveals a heterozygous LRP5 mutation in a 6-year-old boy with vertebral compression fractures and low trabecular bone density. Fahiminiya S; Majewski J; Roughley P; Roschger P; Klaushofer K; Rauch F Bone; 2013 Nov; 57(1):41-6. PubMed ID: 23886840 [TBL] [Abstract][Full Text] [Related]
5. Primary osteoporosis without features of OI in children and adolescents: clinical and genetic characteristics. Laine CM; Koltin D; Susic M; Varley TL; Daneman A; Moineddin R; Cole WG; Mäkitie O; Sochett E Am J Med Genet A; 2012 Jun; 158A(6):1252-61. PubMed ID: 22511589 [TBL] [Abstract][Full Text] [Related]
6. Mutational analysis uncovers monogenic bone disorders in women with pregnancy-associated osteoporosis: three novel mutations in LRP5, COL1A1, and COL1A2. Butscheidt S; Delsmann A; Rolvien T; Barvencik F; Al-Bughaili M; Mundlos S; Schinke T; Amling M; Kornak U; Oheim R Osteoporos Int; 2018 Jul; 29(7):1643-1651. PubMed ID: 29594386 [TBL] [Abstract][Full Text] [Related]
7. Pregnancy-associated osteoporosis with a heterozygous deactivating LDL receptor-related protein 5 (LRP5) mutation and a homozygous methylenetetrahydrofolate reductase (MTHFR) polymorphism. Cook FJ; Mumm S; Whyte MP; Wenkert D J Bone Miner Res; 2014 Apr; 29(4):922-8. PubMed ID: 24014470 [TBL] [Abstract][Full Text] [Related]
8. Osteoporosis-pseudoglioma syndrome: three novel mutations in the LRP5 gene and response to bisphosphonate treatment. Tüysüz B; Bursalı A; Alp Z; Suyugül N; Laine CM; Mäkitie O Horm Res Paediatr; 2012; 77(2):115-20. PubMed ID: 22456437 [TBL] [Abstract][Full Text] [Related]
9. Identification of Rare Rocca MS; Minervini G; Di Nisio A; Merico M; Bueno Marinas M; De Toni L; Pilichou K; Garolla A; Foresta C; Ferlin A Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639175 [TBL] [Abstract][Full Text] [Related]
10. Mutations in LRP5 cause primary osteoporosis without features of OI by reducing Wnt signaling activity. Korvala J; Jüppner H; Mäkitie O; Sochett E; Schnabel D; Mora S; Bartels CF; Warman ML; Deraska D; Cole WG; Hartikka H; Ala-Kokko L; Männikkö M BMC Med Genet; 2012 Apr; 13():26. PubMed ID: 22487062 [TBL] [Abstract][Full Text] [Related]
11. Osteoporosis-pseudoglioma syndrome: clinical, genetic, and treatment-response study of 10 new cases in Greece. Papadopoulos I; Bountouvi E; Attilakos A; Gole E; Dinopoulos A; Peppa M; Nikolaidou P; Papadopoulou A Eur J Pediatr; 2019 Mar; 178(3):323-329. PubMed ID: 30499050 [TBL] [Abstract][Full Text] [Related]
12. More severe phenotype of early-onset osteoporosis associated with recessive form of LRP5 and combination with DKK1 or WNT3A. Caetano da Silva C; Ricquebourg M; Orcel P; Fabre S; Funck-Brentano T; Cohen-Solal M; Collet C Mol Genet Genomic Med; 2021 Jun; 9(6):e1681. PubMed ID: 33939331 [TBL] [Abstract][Full Text] [Related]
13. Polymorphism of LRP5, but not of TNFRSF11B, is associated with a decrease in bone mineral density in postmenopausal Maya-Mestizo women. Canto-Cetina T; Polanco Reyes L; González Herrera L; Rojano-Mejía D; Coral-Vázquez RM; Coronel A; Canto P Am J Hum Biol; 2013; 25(6):713-8. PubMed ID: 24130145 [TBL] [Abstract][Full Text] [Related]
14. Reversing LRP5-dependent osteoporosis and SOST deficiency-induced sclerosing bone disorders by altering WNT signaling activity. Chang MK; Kramer I; Keller H; Gooi JH; Collett C; Jenkins D; Ettenberg SA; Cong F; Halleux C; Kneissel M J Bone Miner Res; 2014 Jan; 29(1):29-42. PubMed ID: 23901037 [TBL] [Abstract][Full Text] [Related]
15. The involvement of the canonical Wnt-signaling receptor LRP5 and LRP6 gene variants with ADHD and sexual dimorphism: Association study and meta-analysis. Grünblatt E; Nemoda Z; Werling AM; Roth A; Angyal N; Tarnok Z; Thomsen H; Peters T; Hinney A; Hebebrand J; Lesch KP; Romanos M; Walitza S Am J Med Genet B Neuropsychiatr Genet; 2019 Sep; 180(6):365-376. PubMed ID: 30474181 [TBL] [Abstract][Full Text] [Related]
16. Common polymorphism in the LRP5 gene may increase the risk of bone fracture and osteoporosis. Xu GY; Qiu Y; Mao HJ Biomed Res Int; 2014; 2014():290531. PubMed ID: 25580429 [TBL] [Abstract][Full Text] [Related]
17. Potential blindness in children of patients with hereditary bone disease. Kheir V; Munier FL; Aubry-Rozier B; Schorderet DF Osteoporos Int; 2016 Feb; 27(2):841-4. PubMed ID: 26243358 [TBL] [Abstract][Full Text] [Related]
18. Analysis of association of LRP5, LRP6, SOST, DKK1, and CTNNB1 genes with bone mineral density in a Slovenian population. Mencej-Bedrac S; Prezelj J; Kocjan T; Komadina R; Marc J Calcif Tissue Int; 2009 Dec; 85(6):501-6. PubMed ID: 19898734 [TBL] [Abstract][Full Text] [Related]
19. A family with osteoporosis pseudoglioma syndrome due to compound heterozygosity of two novel mutations in the LRP5 gene. Cheung WM; Jin LY; Smith DK; Cheung PT; Kwan EY; Low L; Kung AW Bone; 2006 Sep; 39(3):470-6. PubMed ID: 16679074 [TBL] [Abstract][Full Text] [Related]
20. Assessing the contribution of genes involved in monogenic bone disorders to the etiology of atypical femoral fractures. Garcia-Giralt N; Ovejero D; Grinberg D; Nogues X; Castañeda S; Balcells S; Rabionet R Hum Genomics; 2024 Aug; 18(1):87. PubMed ID: 39148098 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]